The Transformation of AML Therapy: Updates in Front-Line and Maintenance Therapies and Considerations for Older Patients
This activity will focus on many novel agents used in the treatment of AML, including targeted agents and the role of hypomethylating agents in maintenance therapy.
BTK Inhibitors in B-Cell Malignancies: Implementing Digital Technology to Optimize Outcomes
This activity will review the clinical data for the use of BTK inhibitors in the management of B-cell malignancies. Potential medication-associated adverse effects will be discussed, with an emphasis on cardiac events.
Optimizing Proteasome Inhibitor Treatment in Multiple Myeloma: The Role of the Pharmacist
This activity will review the place in therapy of PIs for MM, as well as the clinical data supporting their use.
Guiding Precision Medicine in Non−Small Cell Lung Cancer: Recent Updates in New and Emerging Biomarkers
This activity will focus on an overall review of molecular testing in NSCLC, specific targeted therapies, and the role of the pharmacist in caring for patients receiving these targeted therapies.